Webcasted Industry Sessions

Webcasted Industry Sessions

The sessions below were sponsored by Sanofi, GSK and Novavax during the ESPID 2023 Meeting and are intended for HCPs only. 

They are not included in the main event CME/CPD credit.

This sponsored session will focus on raising awareness of the potential impact of invasive meningococcal disease (IMD) in young people and advances in preventative strategies. The distinguished faculty will provide expert perspectives on key challenges as well as discuss the most important unmet needs which still need to be addressed to reduce the burden of disease in children and adolescents, and the impact on their families.

Fernanda Rodrigues
Director of the Paediatric Emergency Service and Infectious Diseases Unit at Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra in Coimbra, Portugal, and a professor at the University of Coimbra School of Medicine.

Prof. Ener Cagri Dinleyici
Professor of Paediatrics at the Eskişehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey.

Elena Moya
Survivor of meningococcal meningitis, and a member of CoMO (Confederation of Meningitis Organisations).

Markus Knuf
Academician and pediatrician in the fields of neonatology, pediatric neurology, infectology and pediatric intensive medicine in his role as chief physician at the Clinic for Pediatrics and Adolescent Medicine in Worms, Germany.

REWATCH SESSION
  • Fernanda Rodrigues – Welcome and Introduction
  • Video Presentation – Protecting our future – Impact and prevention of IMD in the young
  • Ener Cagri Dinleyici – The changing epidemiology of IMD in the post-COVID era
  • Markus Knuf – Expanding our armamentarium against IMD in children and adolescents
  • Elena Moya – Improving awareness and IMD vaccination uptake in younger people – The role of the family and patient associations
  • Live Q&A

RSV is a highly transmissible seasonal virus which can be responsible, in some cases, for unpredictable and potentially severe outcomes in infants. RSV is a frequent cause of respiratory disease, which can include bronchiolitis and/or pneumonia, in infants and is a leading cause of hospitalisations, most of which are in otherwise healthy infants born at term. Historically, a preventive option for the broad infant population has not been available, but newer strategies and approaches could potentially change the RSV disease prevention landscape. This expert-led, interactive symposium will provide an update on strategies and approaches for prevention of RSV disease and considerations for implementing national RSV prevention programmes.

Octavio Ramilo
Chair of the Department of Infectious Diseases at St. Jude Children’s Research Hospital in Memphis, Tennessee.
Paolo Bonanni
Full Professor of Hygiene in the Faculty of Medicine at the University of Florence, Italy, a position he has held since the year 2000.
Joanne Wildenbeest
Paediatric infectious diseases specialist and researcher at the Wilhelmina Children’s Hospital, University Medical Center Utrecht.
REWATCH SESSION
  • Octavio Ramilo – Symposium Welcome and Introductions
  • Joanne Wildenbeest – Strategies and Considerations for Prevention of RSV Disease
  • Paolo Bonanni – Considerations for Implementation of an RSV Disease Prevention Programme
  • Octavio Ramilo – Panel Discussion, Q&A, Close

The goal of this Scientific Theatre session is to understand from expert pediatricians about the main challenges they are facing in their daily practice, including vaccine hesitancy, logistic constraints, interactions with parents, pandemic impact on pediatric vaccination coverage among others. During the event, a pre-recorded video-interview of pediatricians, sharing their best practices and insights related to pediatric vaccination hot topics, will be presented and moderated within an interactive session. 

Giacomo Casabona
Graduated as a Doctor in Medicine in 1990 and specialized in Pharmacology and Clinical Pharmacology in 1994.
Hans Dornbusch
Primary care pediatrician since 2006 and has been member of the Austrian Board of Pediatrics and Adolescent Medicine since 2012.
Philipp Schoof
Pediatrician, graduated in 2001 after medical studies at FSU Jena.
Alessandro Diana
Graduated from the Faculty of Medicine of the UNIGE in 1996 and holds two FMH specialist titles, in pediatrics and in infectious diseases, and a doctorate in medicine since 2004.
Irene Rivero Calle
Bachelor of Medicine by the Autonomous University of Madrid. PhD from the University of Santiago de Compostela.
REWATCH SESSION
  • Giacomo Casabona – Welcome and introduction
  • Hans Dornbusch – Learning from each other: Listen to your colleagues
  • Alessandro Diana – Learning from each other: Listen to your colleagues
  • Philipp Schoof – Learning from each other: Listen to your colleagues
  • Irene Rivero Calle – Learning from each other: Listen to your colleagues
  • Giacomo Casabona – Q&A session, summary and closing

During the Scientific Symposium, a panel of world-renowned experts will discuss the issue of post-pandemic immunity debt, covering mechanism and consequences as well as the resurgence of vaccine-preventable diseases and recent outbreaks in pediatric populations.

Fernanda Rodrigues
Director of the Paediatric Emergency Service and Infectious Diseases Unit and Professor at the School of Medicine at the Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Portugal.
Federico Martinon-Torres
Pediatrician and clinical researcher, currently the coordinator and head of Pediatrics and Director of Translational Pediatrics and Infectious Diseases at the Hospital Clínico Universitario de Santiago (Spain), and Associate Professor in Pediatrics (University of Santiago).
Javier Díez-Domingo
PID specialist, is now director of the vaccine research department of FISABIO, in Valencia, Spain.
Burkhard Lawrenz
Pediatrician. He worked several years as a consultant for pediatrics at the hospital of Kassel and then as the Head of Pediatric Rehabilitation for Oncology and Cardiology at the Hospital Bad Oexen in Bad Oeynhausen, Germany. Since 1990, he has been working as a private primary care pediatrician in Arnsberg, Germany.
REWATCH SESSION
  • Fernanda Rodrigues – Welcome and introduction
  • Federico Martinon-Torres – The long shadow of COVID-19: the resurgence of infectious diseases
  • Javier Díez-Domingo – What is ‘immunity debt’ and what are its impacts
  • Burkhard Lawrenz – Perspectives from a pediatrician – What’s going on in our clinical practice?
  • All Faculty – Roundtable discussion, Q&A session and conclusions

JOIN OUR EXPERTS PANEL in an engaging discussion about MenB vaccination! 2023 is a special momentum as we are celebrating 10 years after the first approval of Bexsero. The objective of this symposium is to share the rational for implementation of new recommendations & National Immunization Programs and to present the recent impacts of MenB vaccination. For that reason, we are inviting different speakers from several countries to share their experience through a discussion.

References: 1. Bexsero SmPC 2022. Available at: https://www.ema.europa.eu/en/documents/productinformation/ bexsero-epar-product-information_en.pdf 2. Thompson MJ et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet;2006;3 67:397-403 3. WHO. Meningitis Factsheet. 2021;1-7. Available at: https://www.who.int/news-room/ factsheets/detail/meningitis. Last accessed: Feb 2023

Isabel Esteves
Graduate Hospital Assistant in Pediatrics. Pediatrics Infectious Diseases Unit, Hospital de Santa Maria – CHULN, Lisbon.
Rino Rappuoli
Elected member of US National Academy of Sciences (NAS), the American Academy of Arts & Sciences (AAAS), the European Molecular Biology Organization (EMBO), the Royal Society of London, and the Accademia Nazionale dei Lincei.
Rino Rappuoli is Scientific Director of the Biotecnopolo di Siena Foundation, Italy.
Federico Martinon-Torres
Pediatrician and clinical researcher, currently the coordinator and head of Pediatrics and Director of Translational Pediatrics and Infectious Diseases at the Hospital Clínico Universitario de Santiago (Spain), and Associate Professor in Pediatrics (University of Santiago).
Roman Chlíbek
Dean of the Faculty of Military Health Sciences of the University of Defence in Hradec Králové and the Head of Epidemiology Department too.

Note that this recording is intended for HCPs only.

REWATCH SESSION
  • Isabel Esteves – Welcome and introduction
  • Rino Rappuoli – Clinical development of 4CMenB vaccine and the latest endogenous complement system to measure immunologically defined vaccine effectiveness against 110 strains
  • Federico Martinon-Torres – Journey from private to publicly funded vaccine MenB vaccination program
  • Isabel Esteves – Impact of MenB National immunization program in Portugal
  • Roman Chlíbek – Key pillars for adolescent MenB Vaccine recommendations and inclusion in the NIP
  • All Faculty – Discussion, Q&A Session
  • Isabel Esteves – Conclusions
  • Present data from the nanoparticle, protein-based adjuvated vaccine of Novavax, discussing pediatric, adolescent, and adult study results, on COVID-19 and influenza prevention.
  • Platform technology aspects, primary, homologous and heterologous booster data, immunogenicity, vaccine efficacy, duration of protection (persistence), variant specific data and safety will be discussed among others.
Chiara Azzari
Full Professor of Pediatrics at University of Florence, graduated in Medicine and Surgery in 1984, PhD in Pediatrics (1989), Specialist in Pediatrics (1993) and in Allergology and Clinical Immunology (2000), Director of the Pediatric Clinic in Meyer Children’s Hospital.
Federico Martinon-Torres
Pediatrician and clinical researcher, currently the coordinator and head of Pediatrics and Director of Translational Pediatrics and Infectious Diseases at the Hospital Clínico Universitario de Santiago (Spain), and Associate Professor in Pediatrics (University of Santiago).
REWATCH SESSION
  • Chiara Azzari – Novavax Vaccine Platform & Adult Data
  • Federico Martinon-Torres – Historical Overview of Recombinant Protein Vaccine Technology Experience & Novavax Adolescent and Paediatric Data
  • Chiara Azzari – COVID-FLU Novavax Co-Administration Data